These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2981904)

  • 1. Biochemical enzyme analysis in acute leukaemia.
    Drexler HG; Gaedicke G; Minowada J
    J Clin Pathol; 1985 Feb; 38(2):117-27. PubMed ID: 2981904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of enzyme markers as a part of multiple marker analysis in leukemia research.
    Drexler HG; Gaedicke G
    Am J Pediatr Hematol Oncol; 1985; 7(3):283-9. PubMed ID: 3000210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme markers in acute leukemias: advances during the last decade.
    Drexler HG; Gaedicke G; Minowada J
    J Natl Cancer Inst; 1984 Jun; 72(6):1283-98. PubMed ID: 6328091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of purine degradative enzymes and terminal deoxynucleotidyl transferase in T cell leukaemias and in normal thymic and post-thymic T cells.
    Ma DD; Massaia M; Sylwestrowicz TA; Price G; Hoffbrand AV
    Br J Haematol; 1983 Jul; 54(3):451-7. PubMed ID: 6305393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme alterations in leukemic cells.
    Dunn NL; Maurer HM
    Am J Hematol; 1982 Dec; 13(4):343-51. PubMed ID: 6297298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adenosine deaminase, purine nucleoside phosphorylase and ecto-5'-nucleotidase--markers of acute leukemia variants].
    Filanovskaia LI; Togo AV; Tsveĭbakh AS; Blinov MN; Alekseev NA
    Vopr Med Khim; 1987; 33(4):16-21. PubMed ID: 2821693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological and immunological markers in acute leukaemia (author's transl)].
    López Borrasca A; González M; Hernández F; Ledesma M; Corrales A; San Miguel J
    Sangre (Barc); 1981; 26(5B):756-82. PubMed ID: 6275558
    [No Abstract]   [Full Text] [Related]  

  • 8. Purine degradative enzymes and immunological phenotypes in chronic B-lymphocytic leukaemia: indications that leukaemic immunocytoma is a separate entity.
    Ho AD; Dörken B; Ma DD; Pezzutto A; Hunstein W; Hoffbrand AV
    Br J Haematol; 1986 Mar; 62(3):545-55. PubMed ID: 3006740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isoenzymes of blast cells in malignant hemopathies: present state and prospectives].
    Vigneron C; Marchand-Arvier M
    Ann Biol Clin (Paris); 1985; 43(2):117-25. PubMed ID: 3000227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine deaminase, purine nucleoside phosphorylase and 5'-nucleotidase activities in infectious mononucleosis.
    Mejer J; Nygaard P; Cohn J; Gadeberg O; Faber V
    Adv Exp Med Biol; 1984; 165 Pt A():249-52. PubMed ID: 6326481
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical markers as indicators of prognosis in acute nonlymphocytic leukemia (ANLL).
    Skoog L; Nordenskjöld B; Ost A; Andersson B; Hast R; Giannoulis N; Reitzenstein P
    Adv Enzyme Regul; 1980; 19():287-93. PubMed ID: 6278867
    [No Abstract]   [Full Text] [Related]  

  • 12. [Degradation of purines in leukocytes in acute nonlymphoblastic leukemias].
    Filanovskaia LI; Blinov MN; Togo AV; Klubovskaia NI; Burmistrova EV
    Vopr Med Khim; 1988; 34(6):71-6. PubMed ID: 2853490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme patterns in normal lymphocyte subpopulations, lymphoid leukaemias and immunodeficiency syndromes.
    Hoffbrand AV; Ma DD; Webster AD
    Clin Haematol; 1982 Oct; 11(3):719-41. PubMed ID: 6293744
    [No Abstract]   [Full Text] [Related]  

  • 14. Purine pathway enzyme abnormalities in acute lymphoblastic leukemia.
    Poplack DG; Blatt J; Reaman G
    Cancer Res; 1981 Nov; 41(11 Pt 2):4821-23. PubMed ID: 6271395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical markers in lymphatic neoplasms].
    Ho AD; Dörken B; Hunstein W
    Dtsch Med Wochenschr; 1984 Sep; 109(36):1375-8. PubMed ID: 6088206
    [No Abstract]   [Full Text] [Related]  

  • 16. Purine metabolizing enzyme activities in lymphoblastic leukemia.
    van Laarhoven JP; Spierenburg GT; de Gast GC; Schouten TJ; De Bruyn CH
    Adv Exp Med Biol; 1984; 165 Pt B():233-40. PubMed ID: 6326501
    [No Abstract]   [Full Text] [Related]  

  • 17. Purine degradative enzymes and terminal transferase in acute myelogenous leukemia: clinical relevance.
    Patmasiriwat P; Anukarahanonta T; Chinprasertsuk S
    Ann Clin Lab Sci; 1993; 23(4):281-9. PubMed ID: 8373133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Purine enzyme activities in lymphocytes from patients with impaired humoral immunity: decreased ecto-5'-nucleotidase activity in agammaglobulinemia (author's transl)].
    Koya M; Yasuda N; Kanoh T; Uchino H; Ueda K
    Nihon Ketsueki Gakkai Zasshi; 1981 Nov; 44(6):1163-8. PubMed ID: 6277136
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzyme and membrane markers in leukaemia: recent developments.
    Hoffbrand AV; Janossy G
    J Clin Pathol; 1981 Mar; 34(3):254-62. PubMed ID: 6785321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymic markers in lymphoproliferative disorders.
    Van Der Weyden MB; Ellims PH; Gan TE
    Am J Hematol; 1983 May; 14(3):301-11. PubMed ID: 6303117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.